NRx Pharmaceuticals, Inc. (NRXP) PT Raised to $34 at D. Boral Capital
Tweet Send to a Friend
D. Boral Capital analyst Jason Kolbert raised the price target on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to $34.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
